Introduction
============

Cell migration is driven by a cycle of cell edge protrusion, ECM adhesion, cell body contraction, and de-adhesion at the cell rear. Coordinating these processes requires integration of forces generated in the F-actin cytoskeleton near the leading cell edge and the formation and disassembly of integrin-based focal adhesions (FA) to the ECM ([@bib9]). Leading edge protrusion is driven by F-actin polymerization in the lamellipodium generating force against the plasma membrane that pushes the leading edge forward and counter-force that pushes lamellipodial F-actin rearward, resulting in retrograde F-actin flow ([@bib29]). Proteins in nascent FA that indirectly link ECM-bound integrin cytoplasmic tails to F-actin are thought to constitute a "molecular clutch" for "engaging" lamellipodial retrograde F-actin flow ([@bib26]; [@bib8]; [@bib16]; [@bib30]). Engagement of retrograde flow at nascent FA may provide friction that reduces flow velocity and harnesses the force of polymerization to drive membrane protrusion and generate ECM traction forces. Force on nascent FA may drive their maturation, during which they grow and recruit cytosolic proteins, which strengthen their linkage to the cytoskeleton and change their signaling properties ([@bib3]; [@bib9]; [@bib24]; [@bib33]). Slowing of F-actin flow at maturing FA is thought to establish a border between the lamellipodium and the adjacent F-actin structure, the lamellum ([@bib1]; [@bib34]). In the lamellum, actomyosin powers slow retrograde F-actin flow ([@bib29]), and forces are transmitted through mature FA to the ECM to drive cell body advance.

Despite extensive evidence for the molecular clutch hypothesis ([@bib26]; [@bib19]; [@bib8]; [@bib16]; [@bib30]), it is unclear which molecules engage F-actin retrograde flow to integrins in FA. Thus, it is not known how F-actin engagement regulates F-actin organization and FA maturation and dynamics. The integrin and F-actin binding protein talin may be part of the molecular clutch, as talin depletion results in excessive retrograde F-actin flow in spreading cells ([@bib43]). Vinculin is an F-actin and talin binding protein that bears force in FA, strengthens and stabilizes FA, is partially coupled to F-actin movement within FA, and is situated in a layer between integrins and F-actin within FA ([@bib15]; [@bib32]; [@bib19]; [@bib20]; [@bib14]; [@bib17]; [@bib23]). Thus, vinculin is also a candidate for a molecular clutch component and a mediator of FA maturation. However, the role of vinculin in regulating the organization and dynamics of F-actin at the leading edge in migrating cells has not been addressed. In addition, vinculin has numerous interactors in FA and lamellipodia including paxillin, Arp2/3, and vasodilator-stimulated phosphoprotein (VASP; [@bib6]), and it is unclear whether vinculin regulates F-actin and FA dynamics by direct or indirect interaction with F-actin.

Here we report the effect of vinculin gene (*Vcl*) disruption on F-actin cytoskeleton and FA dynamics in migrating primary mouse embryonic fibroblasts (MEF). We find that vinculin is critical to coordinate F-actin organization and FA dynamics at the leading edge. Characterization of a vinculin point mutant that specifically disrupts F-actin binding shows that vinculin interaction with F-actin is critical for these functions.

Results
=======

We sought to determine the role of vinculin in F-actin and FA organization and dynamics in cells lacking vinculin. To circumvent long-term adaptation of cells to vinculin loss, we generated vinculin-deficient primary MEF by in vitro cre recombinase--mediated excision of essential *Vcl* sequences in MEF from E13.5 *Vcl*^flox/flox^ embryos ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp1}; [@bib42]). Cre-mediated *Vcl* disruption resulted in complete loss of vinculin protein within 4 d (Fig. S1 B). Compared with control (*Vcl*^flox/flox^/adeno-control) MEF, *Vcl* knockout (*Vcl*-KO; genotype *Vcl*^flox/flox^/adeno-cre) MEF were less spread, displayed narrow lamellae, lobular lamellipodia, and long tails (Fig. S1, C and D; and [Video 1](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp2}) and exhibited an increased random migration velocity (Fig. S1, E and F; and [Video 2](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp3}), all similar to vinculin-deficient clonal MEF and F9 cells ([@bib38]; [@bib40],[@bib41]; [@bib27]).

Vinculin organizes lamellipodia and lamella F-actin and mediates F-actin retrograde flow engagement at FA to generate ECM traction
----------------------------------------------------------------------------------------------------------------------------------

To determine the role of vinculin in regulating leading edge F-actin dynamics, we imaged F-actin and FA in control and *Vcl*-KO MEF microinjected with X-rhodamine actin and EGFP-paxillin cDNA by time-lapse spinning disk confocal (SDC) microscopy and analyzed the images by quantitative fluorescent speckle microscopy (qFSM; [@bib29]). Control MEF exhibited typical organization of leading edge F-actin dynamics ([Fig. 1 A](#fig1){ref-type="fig"}), characterized by a lamellipodium with rapid retrograde flow (∼0.45 µm/min) in a narrow (∼1--3 µm) band along the cell edge adjacent to a broad lamellum region located ∼5--15 µm behind the leading edge where F-actin exhibited slower retrograde flow (∼0.15 µm/min; [Fig. 1, B \[arrow\] and C](#fig1){ref-type="fig"}; and [Video 3](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp4}). The junction between fast retrograde flow in the lamellipodium and slower flow in the lamellum corresponded to the site of nascent FA, as shown previously ([Fig. 1 D](#fig1){ref-type="fig"} and [Video 4](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp5}; [@bib19]). *Vcl*-KO MEF exhibited a similar organization of F-actin dynamics with fast F-actin retrograde flow in the lamellipodium and slower flow in the lamellum ([Fig. 1 B](#fig1){ref-type="fig"}, arrowhead). However, F-actin flow in both lamellipodium and lamellum of *Vcl*-KO MEF was significantly faster than in the same regions of control cells ([Fig. 1 C](#fig1){ref-type="fig"}). Thus, vinculin slows F-actin retrograde flow in the leading edge of migrating cells.

![**Vinculin mediates F-actin flow engagement in maturing FA and high ECM traction.** (A) Alexa Fluor 488--phalloidin staining of F-actin (green), paxillin (red), and myosin light chain-2 (MLC-2; blue; asterisk) immunofluorescence staining of a primary control MEF. Bars, 5 µm. (B) qFSM of control and *Vcl*-KO MEF microinjected with X-rhodamine actin and EGFP-paxillin cDNA. (left to right) SDC-FSM images of F-actin (Bar, 5 µm); F-actin flow maps (Bar, 2 μm/min); F-actin speed maps (μm/min); and EGFP-paxillin image showing FA location. Note a wider band of fast retrograde F-actin flow in *Vcl*-KO (arrowhead) compared to control (arrow) MEF. 10-s frame rate. (C) Box and whisker plot of mean F-actin flow velocities in lamellipodium (LP) and lamellum (LM) of control and *Vcl*-KO MEF, calculated from qFSM F-actin speed maps. *n* = 30 (control) and *n* = 40 (*Vcl*-KO) time points during protrusion (6--8 cells/condition); means indicated; \*, P \< 0.01, Mann-Whitney *U* test. (D) Overlays of EGFP-paxillin (left) and F-actin flow maps (right) of control and *Vcl*-KO MEF. Bars: (left) 2 µm; (right, flow), 2 μm/min. (E) Box and whisker plot of F-actin flow velocities within and outside of segmented FA during protrusion phases (6--8 cells per condition, qFSM, X-rhodamine actin/EGFP-paxillin); *n* = 1,000 per group (uniformly sampled among all segmented FA of each group, or among all pixels outside of segmented FA in a given region); means indicated; \*, P \< 0.0001, Mann-Whitney *U* test. (F) High resolution TFM of EGFP-paxillin expressing control and *Vcl*-KO MEF on FN-coated polyacrylamide substrates. (left to right) EGFP-paxillin SDC images and ECM traction maps (kPa). Arrows (control) and arrowheads (*Vcl*-KO) denote individual FA. Bar, 5 µm. (G) Box and whisker plot of ECM traction stresses of *n* = 48 (control) and *n* = 20 (*Vcl*-KO) segmented FA (eight control and six *Vcl*-KO MEF); means indicated; \*, P \< 0.01, Student's *t* test.](JCB_201303129R_Fig1){#fig1}

To test whether vinculin modulates F-actin flow locally within FA, we developed algorithms to measure F-actin flow specifically within or outside of segmented FA ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp6} and [computational source code](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp7} in online supplemental material). This showed a comparable reduction of F-actin flow velocity within nascent FA, compared with lamellipodial areas outside nascent FA, in both control and *Vcl*-KO MEF ([Fig. 1 E](#fig1){ref-type="fig"}), suggesting that vinculin was not required to slow F-actin flow at FA in the nascent state. However, in control MEF, F-actin flow velocity in mature FA was significantly lower than in nascent FA, whereas in *Vcl*-KO MEF, F-actin flow velocity was similar in nascent and mature FA ([Fig. 1 E](#fig1){ref-type="fig"}). Consistent with this finding, control MEF showed a rapid drop of F-actin flow velocity ∼1.5 µm behind the leading edge at the site of nascent FA, whereas flow velocity in FA of *Vcl*-KO MEF dropped more gradually with distance from the leading edge, where FA undergo maturation (Fig. S2 B). Thus, vinculin is not required to slow F-actin flow at nascent FA in the lamellipodium but is critical for slowing F-actin flow in mature FA and for maintaining a steep flow velocity gradient between lamellipodium and lamellum.

To test whether vinculin mediates coupling of F-actin retrograde flow to the ECM to generate traction at FA, we used high resolution traction force microscopy (TFM; [@bib31]) to measure ECM traction stresses at individual FA in control and *Vcl*-KO MEF expressing EGFP-paxillin. As the resolution of our TFM was not sufficient to analyze nascent FA, we restricted our analysis to mature FA. This revealed significantly lower ECM-traction stresses generated by *Vcl*-KO compared with control FA ([Fig. 1, F and G](#fig1){ref-type="fig"}). Together, these results show that vinculin is required to slow F-actin retrograde flow and increase traction forces in maturing FA, suggesting that vinculin mediates F-actin flow engagement to the ECM during FA maturation.

Because engagement of F-actin flow at FA is thought to limit the width of the lamellipodium and to establish a border between lamellipodium and lamellum ([@bib29]; [@bib1]; [@bib34]), we sought to test whether vinculin affected the spatial organization of lamellipodium and lamellum. We localized F-actin and the lamellipodial protein cortactin or the lamellum protein phosphoserine19 myosin regulatory light chain-2 (pS19MLC2) in control and *Vcl*-KO MEF ([@bib39]; [@bib29]; [@bib18]; [@bib25]). Line scans of staining intensity across the leading edge of control MEF revealed a sharply defined, narrow band of cortactin that colocalized with dense lamellipodial F-actin ([Fig. 2, A \[arrow\], D, and E](#fig2){ref-type="fig"}). In contrast, cortactin staining at the leading edge of *Vcl*-KO MEF was significantly broader ([Fig. 2, A \[asterisk\], D, and E](#fig2){ref-type="fig"}) with a less defined border ([Fig. 2 A](#fig2){ref-type="fig"}, arrowhead). Line scans across the lamellum revealed a sigmoidal gradient with low amounts of pS19MLC2 near the cell edge in control MEF ([Fig. 2, B \[asterisk\] and C](#fig2){ref-type="fig"}), whereas *Vcl*-KO MEF displayed a more linear gradient with considerable pS19MLC2 staining near the cell edge ([Fig. 2, B \[arrowhead\] and C](#fig2){ref-type="fig"}). Thus, consistent with the requirement of vinculin to engage F-actin flow at FA, vinculin is required to restrict lamellipodium width and to define a sharp border that spatially segregates lamellipodium and lamellum.

![**Vinculin establishes a lamellipodium--lamellum border.** (A) Cortactin immunofluorescence (purple) and Alexa Fluor 488--phalloidin staining (green) of control and *Vcl*-KO MEF. Note wider lamellipodium in *Vcl*-KO (asterisk) and diffuse lamellipodium--lamellum border (arrowhead) compared to control MEF (arrow). Bar, 5 µm. (B) pS19MLC2 immunofluorescence (purple) and Alexa Fluor 488--phalloidin staining (green) of control and *Vcl*-KO MEF. Note low amount of pS19MLC2 in the distal lamellum of control (asterisk) and abundant pS19MLC2 in the distal lamellum of *Vcl*-KO (arrowhead) MEF. Bar, 10 µm. (C) pS19MLC2 and Alexa Fluor 488--phalloidin fluorescence intensity distribution along line scans perpendicular to the leading edge (mean of 25 cells/condition). (D) Cortactin fluorescence intensity distribution along line scans, placed perpendicularly to the cell edge through the lamellipodium (mean of 60 scans/condition). Width of the distribution at half maximal intensity (I~max/2~) indicated. (E) Box and whisker plot of lamellipodium width at I~max/2~ of cortactin line scans, placed through the lamellipodium at 15--20-µm intervals along the leading edge; *n* = 219 (control) and 243 (*Vcl*-KO) scans of 25 cells/genotype; means indicated; \*, P \< 0.0001, Mann-Whitney *U* test.](JCB_201303129_Fig2){#fig2}

Isoleucine 997 mutation to alanine \[ΔAB\] perturbs vinculin binding to F-actin
-------------------------------------------------------------------------------

To test whether vinculin regulates leading edge F-actin dynamics and organization through direct interaction with F-actin, we introduced a mutation into the vinculin tail domain that impairs F-actin binding. ΔAB impairs binding of the isolated vinculin tail domain to F-actin, but does not affect tail domain structure or acidic phospholipid binding in vitro (unpublished data). In the context of full-length vinculin ΔAB ([Fig. 3 A](#fig3){ref-type="fig"}) significantly reduces vinculin cosedimentation with F-actin in the presence of the vinculin-activating peptide IpaA ([@bib4]; [Fig. 3 B](#fig3){ref-type="fig"}). This corresponds to an ∼10-fold decrease in the apparent dissociation constant for ΔAB (1.4 ± 0.2 µM) compared with WT (12 ± 2 µM) vinculin, resulting in an equilibrium shift of F-actin--bound versus unbound ΔAB vinculin ([Fig. 3, B and C](#fig3){ref-type="fig"}). To visualize the effect of ΔAB vinculin on F-actin organization in vitro we used fluorescence microscopy and phalloidin staining ([Fig. 3 D](#fig3){ref-type="fig"}). In the absence of IpaA, neither wild-type (WT) nor ΔAB vinculin induced F-actin bundles. In contrast, in the presence of IpaA, WT vinculin induced large F-actin bundles, whereas ΔAB vinculin did not ([Fig. 3, D and E](#fig3){ref-type="fig"}). Because F-actin binding may be critical for the release of vinculin head--tail interaction to allow vinculin activation ([@bib2]), we included additional mutations (N773/E775A) to reduce the affinity of head--tail interaction to partially activate (PA) vinculin ([@bib10]) in both WT (PA vinculin) and ΔAB (PA-ΔAB vinculin) contexts as controls in our in vivo experiments ([Fig. 3 A](#fig3){ref-type="fig"}). F-actin binding experiments confirmed that PA-ΔAB vinculin was still able to be activated by IpaA, despite its decreased affinity for F-actin ([Fig. 3, F and G](#fig3){ref-type="fig"}). Importantly, expression of EGFP-tagged WT, PA, ΔAB, and PA-ΔAB vinculin variants in *Vcl*-KO MEF followed by immunostaining showed that all variants colocalized with paxillin in nascent and mature FA (see [Figs. 6 A](#fig6){ref-type="fig"} and S5).

![**ΔAB perturbs vinculin binding to F-actin.** (A) Point mutations introduced into full-length vinculin to analyze the role of vinculin--F-actin binding. PA, N773A/E775A point mutations in the vinculin head domain resulting in partial activation of WT vinculin; ΔAB, I997A mutation in the vinculin tail domain perturbing F-actin binding/bundling of WT vinculin; PA-ΔAB, N773A/E775A/I997A point mutations resulting in partial activation of ΔAB vinculin. cDNAs were expressed as EGFP fusion constructs. (B) SDS-PAGE of supernatant and pellet after high-speed cosedimentation of WT and ΔAB vinculin with F-actin at indicated concentrations in the absence or presence of activating peptide IpaA. S, supernatant; P, pellet. (C) Densitometric quantification of F-actin cosedimentations shown in B. Data were fit for single site, saturation binding. Error bars show SEM. (D) Fluorescence micrographs of actin filaments polymerized in the absence or presence of IpaA and WT or ΔAB vinculin. Bar, 10 µm. (E) Bar diagram of F-actin bundling induced by WT and ΔAB vinculin in the absence or presence of IpaA; *n* = 1 (WT -- IpaA), *n* = 1 (WT + IpaA), *n* = 3 (ΔAB -- IpaA), and *n* = 3 (ΔAB + IpaA). Error bars show standard deviation. (F) SDS-PAGE of supernatant (S) and pellet (P) after high-speed cosedimentation of WT, PA, and PA-ΔAB vinculin with actin at indicated concentrations in the absence or presence of IpaA. (G) Densitometric quantification of F-actin cosedimentations shown in F. Data were fit for single site, saturation binding. Error bars show SEM.](JCB_201303129_Fig3){#fig3}

Vinculin--F-actin binding restricts lamellipodia width and slows F-actin flow in mature FA
------------------------------------------------------------------------------------------

To test whether vinculin regulates leading edge F-actin by direct F-actin binding, we performed SDC microscopy of F-actin dynamics and immunostaining of cortactin in *Vcl*-KO MEF expressing EGFP-tagged WT, PA, ΔAB, or PA-ΔAB vinculin and monomeric Apple (mApple)--actin ([Fig. 4 A](#fig4){ref-type="fig"} and [Videos 5 and 6](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp8}). qFSM and kymograph analysis showed that add-back expression of WT or PA vinculin rescued the effects of *Vcl*-KO, reducing F-actin flow velocity in *Vcl*-KO MEF to levels similar to control MEF both in the lamellipodium and within maturing FA in the lamellum ([Fig. 4, A, C, and D](#fig4){ref-type="fig"}; and [Fig. 1 C](#fig1){ref-type="fig"}). In contrast, add-back of ΔAB or PA-ΔAB vinculin to *Vcl*-KO MEF only slightly rescued the effects of *Vcl*-KO on F-actin retrograde flow, showing a decrease in F-actin flow in lamellipodia and maturing FA compared with Vcl-KO, but not to the same extent as add-back of WT vinculin. Immunostaining for cortactin revealed that add-back expression of either WT or PA vinculin in *Vcl*-KO MEF rescued the effects of vinculin deficiency, exhibiting a narrow cortactin band along the leading edge similar to control MEF ([Fig. 4 B](#fig4){ref-type="fig"}, arrows; and [Fig. 1 H](#fig1){ref-type="fig"}). In contrast, *Vcl*-KO MEF expressing ΔAB or PA-ΔAB vinculin exhibited a significantly wider cortactin band with a diffuse border, similar to those in nontransfected *Vcl*-KO MEF ([Fig. 4, B \[arrowheads\] and E](#fig4){ref-type="fig"}; and [Fig. 1 H](#fig1){ref-type="fig"}). Together, these results show that the direct interaction of vinculin with F-actin is necessary to slow F-actin flow in lamellipodia and within mature FA and to restrict lamellipodium width to define a sharp lamellipodium--lamellum border. However, other activities of vinculin may be required for full inhibition of F-actin flow by vinculin.

![**Vinculin--F-actin binding restricts lamellipodium width and limits F-actin flow velocity in lamellipodium and mature FA.** (A) qFSM of *Vcl*-KO MEF expressing mApple-actin and the indicated EGFP-vinculin cDNA. (left to right) SDC-FSM images of F-actin (Bar, 5 µm); F-actin flow maps (Bar, 2 μm/min); and F-actin speed maps (μm/min). 5-s frame rate. (B) Cortactin immunofluorescence (purple) staining of *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA. Note distinct, narrow cortactin band in WT- and PA-vinculin (arrows) expressing *Vcl*-KO MEF and wider, diffuse cortactin band in nontransfected, ΔAB-, and PA-ΔAB-vinculin (arrowheads) expressing *Vcl*-KO MEF. Bars, 2 µm. (C) Box and whisker plot of mean F-actin flow velocities in protruding lamellipodia of *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA, data calculated from qFSM F-actin speed maps; *n* = 70 (nontransfected), *n* = 120 (WT), *n* = 35 (PA), *n* = 110 (ΔAB), and *n* = 45 (PA-ΔAB) time points during protrusion (7--22 cells/condition; means indicated; \*, P \< 0.01, Mann-Whitney *U* test). (D) Box and whisker plot of local F-actin flow velocity within maturing FA in *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA; *n* = 41 (nontransfected), *n* = 32 (WT), *n* = 22 (PA), *n* = 30 (ΔAB), and *n* = 22 (PA-ΔAB) FA of 7--16 cells/condition. EGFP-vinculin mutants were used as FA markers (EGFP-paxillin, nontransfected) and F-actin flow was measured on kymographs; means indicated; \*, P \< 0.02, Student's *t* test. (E) Box and whisker plot of lamellipodium (LP) width at I~max/2~ of cortactin line scans, placed through the lamellipodia at regular intervals; *n* = 145 (nontransfected), 160 (WT), 150 (PA), 195 (ΔAB), and 195 (PA-ΔAB) scans from 29--39 cells/condition; means indicated; \*, P \< 0.001, Mann-Whitney *U* test.](JCB_201303129R_Fig4){#fig4}

Vinculin promotes nascent FA formation and turnover in lamellipodia and slows FA growth in the lamellum
-------------------------------------------------------------------------------------------------------

The formation and turnover of nascent FA occurs within protruding lamellipodia, whereas a small fraction of nascent FA that do not disassemble in lamellipodia go on to mature in the lamellum ([@bib9]). Although vinculin and its F-actin binding tail domain are required for force-mediated stabilization of mature FA ([@bib20]; [@bib7]), it remains unclear how vinculin and its F-actin binding activity specifically regulate nascent FA formation and turnover in the lamellipodium and the transition from nascent to maturing FA in the lamellum. To answer this question, we characterized the role of vinculin and its F-actin binding activity in FA organization and dynamics in the leading edge.

We first verified that deletion of vinculin had no major effects on FA composition by immunofluorescence analyses of talin, paxillin, FAK, zyxin, VASP, and β1 integrin in V*cl*-KO MEF ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp9}). This also revealed that control MEF displayed numerous small, peripheral FA along the cell edge and fewer mature FA in the lamellum, whereas peripheral FA were sparse and mature FA were more prominent in *Vcl*-KO MEF ([Fig. 5 A](#fig5){ref-type="fig"}), regardless of the FA protein examined (Fig. S3). This suggests that vinculin may affect both nascent FA formation and FA maturation.

![**Vinculin promotes nascent FA formation and turnover in lamellipodia and slows FA growth in the lamellum.** (A) Paxillin immunofluorescence and Alexa Fluor 488--phalloidin staining of F-actin in control and *Vcl*-KO MEF. Note abundant nascent FA in control (arrows) but not *Vcl*-KO (arrowhead) lamellipodia and prominent FA in the distal lamellum of *Vcl*-KO but not control MEF (asterisks). Bars, 10 µm. (B) Paxillin and F-actin (phalloidin) intensity distribution along line scans perpendicular to the leading edge (mean of 25 cells/condition). (C) Box and whiskerplot of mean FA size in *n* = 10 control and *n* = 10 *Vcl*-KO MEF. FA marker paxillin; means indicated; Student's *t* test. (D) Box and whisker plot of FA size distribution in *n* = 10 (control) and *n* = 10 (*Vcl*-KO) MEF; FA marker paxillin; means indicated; \*, P \< 0.05, Student's *t* test. (E) TIRF micrographs of live control and *Vcl*-KO MEF expressing EGFP-paxillin, showing FA at t = 0 s (green) and t = 92 s (purple). Lamellipodia borders outlined based on coexpressed mApple-actin ([Video 7](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp10}). Note the high density of newly formed nascent FA in control compared to *Vcl*-KO MEF (asterisks) and the high number of nascent FA undergoing maturation in *Vcl*-KO compared to control MEF (arrows). 2-s frame rate. Bar, 2 µm. (F) Box and whisker plot of nascent FA formation density in protruding lamellipodia of control and *Vcl*-KO MEF; *n* = 30 (control) and *n* = 35 (*Vcl*-KO) protrusion sequences (6 cells/genotype); means indicated; \*, P \< 0.001, Student's *t* test. (G) Maturation fraction among 55 (control) and 65 (*Vcl*-KO) nascent FA (6 cells/genotype). \*, P \< 0.001, Student's *t* test. (H) SDC fluorescence time-lapse images of FA growth in control and *Vcl*-KO MEF; FA marker EGFP-paxillin; 10-s frame rate. Red line shows line scan positioning parallel to the long axis of FA for kymograph analyses (right panels) of FA growth (and local F-actin flow velocity; see [Fig. 8 A](#fig8){ref-type="fig"}). D, distance; T, time. Bar, 2 µm. (I) Box and whisker plot of FA (paxillin) growth rate in *n* = 10 (control) and *n* = 11 (*Vcl*-KO) MEF (6--10 FA/cell); means indicated; \*, P \< 0.001, Student's *t* test.](JCB_201303129_Fig5){#fig5}

To test whether loss of vinculin specifically affects nascent FA in the lamellipodium, we analyzed FA size and spatial distribution relative to F-actin structures in control and *Vcl*-KO MEF by immunofluorescence staining of paxillin as FA marker and phalloidin to label F-actin ([Fig. 5 A](#fig5){ref-type="fig"}). Paxillin and F-actin intensity line scans across lamellipodia and lamella revealed high paxillin intensity within the first ∼3 µm from the cell edge in the F-actin--dense lamellipodium of control MEF. In contrast, *Vcl*-KO MEF lacked paxillin in the lamellipodium and instead showed a broader paxillin peak at ∼5--15 µm from the cell edge in the lamellum ([Fig. 5 B](#fig5){ref-type="fig"}). Quantification of individual FA size showed that *Vcl*-KO MEF exhibited a slight increase in mean FA size ([Fig. 5 C](#fig5){ref-type="fig"}) that was caused by a significant decrease in the fraction of nascent (\<0.25 µm^2^) FA and a significant increase in the fraction of midsized (0.25--3 µm^2^) mature FA compared with control MEF ([Fig. 5 D](#fig5){ref-type="fig"} and [Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp11}). Thus, vinculin promotes nascent FA in the lamellipodium and inhibits mature FA in the lamellum.

To test how vinculin altered the balance between nascent and mature FA, we analyzed FA dynamics in cells coexpressing EGFP-paxillin to label FA and mApple-actin to label lamellipodia by time-lapse total internal reflection fluorescence (TIRF) microscopy ([Fig. 5 E](#fig5){ref-type="fig"} and [Video 7](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp12}). This revealed that lamellipodial protrusion in control MEF was accompanied by a high density of nascent FA formation (FA formed per micrometer squared protrusion), whereas nascent FA formation density in *Vcl*-KO MEF was strongly reduced ([Fig. 5, E and F](#fig5){ref-type="fig"}). Because mature FA arise by growth of nascent FA ([@bib9]), we reasoned that the increase in mature FA in cells lacking vinculin could result from reduced nascent FA disassembly and increased maturation frequency. To test this, we quantified the percentage of nascent FA that did not disassemble within the lamellipodium and went on to elongate in the lamellum. In control cells, most nascent FA disassembled and only 1.9% matured, whereas in *Vcl*-KO MEF, although fewer nascent FA were formed, a larger fraction (22%) of them matured ([Fig. 5 G](#fig5){ref-type="fig"}). To test whether vinculin also regulated the growth of FA after the onset of maturation, we measured FA growth rate in control and *Vcl*-KO MEF expressing EGFP-paxillin as an FA marker and microinjected with X-rhodamine actin using kymograph analyses of SDC time-lapse sequences ([Fig. 5 H](#fig5){ref-type="fig"}). This revealed that FA in *Vcl*-KO MEF elongated significantly faster than FA in control MEF ([Fig. 5 I](#fig5){ref-type="fig"} and [Video 8](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp13}). Neither assembly time (time to maximal paxillin fluorescence intensity) nor lifetime of nascent FA were significantly affected by vinculin loss (unpublished data). Together, these results demonstrate that vinculin promotes the formation and turnover of nascent FA in the lamellipodium, inhibits the transition of nascent FA to maturing FA, and slows the rate of maturation in the lamellum.

Vinculin activation and F-actin binding promote nascent FA formation and turnover, whereas F-actin binding slows FA growth
--------------------------------------------------------------------------------------------------------------------------

To determine the role of vinculin--F-actin binding in FA formation and maturation, we analyzed FA in lamellipodia of *Vcl*-KO MEF expressing WT, PA, ΔAB, or PA-ΔAB EGFP-tagged vinculin variants by immunofluorescence staining of paxillin and cortactin ([Fig. 6 A](#fig6){ref-type="fig"}). Line scans across the leading edge of *Vcl*-KO MEF expressing WT or PA vinculin showed that add-back of these vinculin variants rescued the effects of vinculin loss, as indicated by a peak of paxillin intensity within the cortactin-rich lamellipodium and low paxillin levels in the lamellum ([Fig. 6 B](#fig6){ref-type="fig"}), similar to controls ([Fig. 5 B](#fig5){ref-type="fig"}). In contrast, *Vcl*-KO MEF expressing ΔAB or PA-ΔAB vinculin lacked the peak of paxillin in the lamellipodium, but exhibited a broad peak of paxillin across the lamellum comparable to nontransfected *Vcl*-KO MEF ([Fig. 6 B](#fig6){ref-type="fig"}). Quantification of individual FA area revealed that add-back of WT vinculin in *Vcl*-KO cells fully rescued the effects of *Vcl*-KO, decreasing the mean FA size to values similar to control ([Fig. 6 C](#fig6){ref-type="fig"} and [Fig. 5 C](#fig5){ref-type="fig"}) by gain of nascent FA and loss of midsized and large FA ([Fig. 6 D](#fig6){ref-type="fig"}). In contrast, add-back of either PA-ΔAB vinculin or the vinculin head domain lacking the F-actin binding tail (Vh; amino acids 1--821) to *Vcl*-KO MEF did not rescue the effects of loss of vinculin on FA size, with FAs exhibiting a significantly larger size compared with add-back of WT vinculin and size distribution that was indistinguishable from *Vcl*-KO MEF ([Fig. 6, C and D](#fig6){ref-type="fig"}). This is consistent with the notion that activated vinculin promotes enlarged FA ([@bib20]; [@bib7]), but further suggests that F-actin binding in the tail of activated vinculin is required for limiting FA size. Add-back of PA or ΔAB vinculin to *Vcl*-KO partially rescued the effects of vinculin deficiency, reducing FA size via gain of nascent FA and loss of midsized FA, but not to the same extent as add-back of WT vinculin ([Fig. 6, C and D](#fig6){ref-type="fig"}). Together, these data demonstrate that both vinculin activation and F-actin binding are required for promoting nascent FA and reducing mature FA.

![**Vinculin activation and F-actin binding are required for promoting nascent FA and reducing mature FA.** (A) SDC fluorescence micrographs of *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA, immunofluorescence-stained for cortactin and paxillin. Bars, 2 µm. (B) Paxillin intensity distribution along line scans perpendicular to the leading edge of *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA (mean of 20 cells/condition). (C) Box and whisker-plot of mean FA size in *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA and immunofluorescence stained for paxillin as FA marker; *n* = 11 (nontransfected), *n* = 9 (WT), *n* = 9 (PA), *n* = 12 (ΔAB), *n* = 10 (PA-ΔAB), and *n* = 17 (Vh) cells/condition; means indicated; \*, P \< 0.05, Student's *t* test. (D) Box and whisker plot of FA size distribution in *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA and immunofluorescence stained for paxillin as FA marker; *n* = 11 (nontransfected), *n* = 9 (WT), *n* = 9 (PA), *n* = 12 (ΔAB), *n* = 10 (PA-ΔAB), and *n* = 17 (Vh) cells/condition; means indicated; \*, P \< 0.05, Student's *t* test.](JCB_201303129_Fig6){#fig6}

To determine how activation and F-actin binding of vinculin regulated the balance between nascent and mature FA, we imaged FA dynamics in *Vcl*-KO MEF expressing WT, PA, ΔAB, or PA-ΔAB EGFP-vinculin to label FA and mApple-actin to label lamellipodia by TIRF microscopy ([Fig. 7 A](#fig7){ref-type="fig"} and [Videos 9 and 10](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp14}). We first confirmed the suitability of EGFP-tagged vinculin mutants as markers for the analysis of nascent FA assembly and maturation by cotransfecting *Vcl*-KO MEF with EGFP-vinculin variants (WT, PA, ΔAB, or PA-ΔAB) and mApple-paxillin and testing the colocalization of paxillin and vinculin variants in TIRF image series of live cells ([Fig. S5](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp15}). Analysis of nascent FA assembly and maturation during lamellipodial protrusion showed that add-back reexpression of either WT or PA vinculin in *Vcl*-KO MEF rescued the effects of vinculin loss, restoring both the high formation density and low maturing fraction of nascent FA to levels comparable to those in control ([Fig. 7, B and C](#fig7){ref-type="fig"}; Video 9; and [Fig. 5, F and G](#fig5){ref-type="fig"}). In contrast, add-back of either ΔAB or PA-ΔAB vinculin variants to *Vcl*-KO MEF did not rescue the effects of *Vcl*-KO on either formation density or maturing fraction of nascent FA ([Fig. 7, B and C](#fig7){ref-type="fig"}; and Video 10). Analysis of the growth rate of maturing FA on SDC time-lapse series of *Vcl*-KO MEF expressing EGFP-tagged WT, PA, ΔAB, or PA-ΔAB vinculin, or EGFP-paxillin (nonrescued *Vcl*-KO MEF) to label FA and mApple-actin showed that add-back expression of either WT or PA vinculin in *Vcl*-KO MEF rescued the effects of vinculin deficiency, restoring the slow FA growth rate seen in control MEF ([Fig. 7 D](#fig7){ref-type="fig"} and [Fig. 5, H and I](#fig5){ref-type="fig"}). In contrast, add-back of ΔAB or PA-ΔAB vinculin to *Vcl*-KO MEF did not fully rescue the effects of vinculin loss on FA growth rate, but reduced it to levels significantly lower than in *Vcl*-KO MEF. Thus, vinculin activation and binding to F-actin are both required to promote the formation and turnover of a high density of nascent FA during lamellipodial protrusion, whereas vinculin--F-actin binding and activation are required but not sufficient for slowing the rate of FA growth during maturation in the lamellum.

![**Vinculin activation and F-actin binding promote nascent FA formation and turnover, whereas vinculin--F-actin binding slows FA growth and vinculin activation is limiting for FA stabilization.** (A) TIRF micrographs of live *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA and mApple-actin ([Videos 9--10](http://www.jcb.org/cgi/content/full/jcb.201303129/DC1){#supp16}), showing FA at t = 0 s (green) and t = 90 s (purple); 3-s frame rate. Bar, 2 µm. (B) Box and whisker plot of nascent FA formation density in protruding lamellipodia of *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA; *n* = 19 (nontransfected), *n* = 20 (WT), *n* = 12 (PA), *n* = 12 (ΔAB), and *n* = 12 (PA-ΔAB) protrusion sequences (6--10 cells/genotype); means indicated; \*, P \< 0.002, Student's *t* test. (C) Maturation fraction among \>200 nascent FA in protruding lamellipodia of *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA; *n* = 19 (nontransfected, EGFP-paxillin), *n* = 20 (WT), *n* = 12 (PA), *n* = 12 (ΔAB), and *n* = 12 (PA-ΔAB) protrusion sequences (6--10 cells/genotype); means indicated; \*, P \< 0.0001, Student's *t* test. (D) Box and whisker plot of FA growth rate in *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA; *n* = 41 (nontransfected, EGFP-paxillin), *n* = 32 (WT), *n* = 22 (PA), *n* = 30 (ΔAB), and *n* = 22 (PA-ΔAB) FA of 9--16 cells/condition; means indicated; \*, P \< 0.002, Student's *t* test. (E) Box and whisker plot of FA persistence (fraction of FA persistent for \>1 h) of *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA, recorded by laser scanning confocal microscopy. EGFP-vinculin (variants) as FA marker; frame rate of 2 min; *n* = 9 (nontransfected, i.e., EGFP-paxillin transfected), *n* = 9 (WT), *n* = 8 (PA), *n* = 7 (ΔAB), *n* = 8 (PA-ΔAB), and *n* = 9 (Vh) cells/condition; means indicated; \*, P \< 0.005, Student's *t* test.](JCB_201303129_Fig7){#fig7}

Recent studies have shown that overexpression of activated vinculin or vinculin lacking the F-actin binding tail domain promote contractility-independent FA hypertrophy and stabilization ([@bib20]; [@bib7]), suggesting that vinculin activation and F-actin binding may promote FA maturation. Our finding that vinculin--F-actin binding inhibits the transition of nascent FA to maturation and slows FA growth appears somewhat contradictory to these data. To determine the requirement for the vinculin--F-actin interaction and vinculin activation in FA stabilization, we imaged *Vcl*-KO MEF expressing GFP-tagged WT, PA, ΔAB, PA-ΔAB vinculin, or isolated Vh by confocal microscopy and quantified FA persistence as the fraction of initial FA that did not disassemble after 1 h of imaging ([Fig. 7 E](#fig7){ref-type="fig"}). FA persistence in *Vcl*-KO MEF was strongly reduced compared with *Vcl*-KO MEF expressing WT vinculin ([Fig. 7 E](#fig7){ref-type="fig"}), consistent with the role of vinculin in stabilizing FA. In addition, add-back expression of either PA vinculin or Vh also rescued the effects of vinculin loss, promoting increased FA persistence comparable to levels in *Vcl*-KO MEF expressing WT vinculin ([Fig. 7 E](#fig7){ref-type="fig"}), indicating that activation of vinculin is critical to FA stabilization. In line with this, add-back of PA-ΔAB vinculin to *Vcl*-KO MEF rescued the effects of vinculin, whereas add-back of ΔAB vinculin did not ([Fig. 7 E](#fig7){ref-type="fig"}). Interestingly, neither PA nor PA-ΔAB vinculin or Vh increased FA persistence beyond levels seen in WT vinculin-expressing cells, suggesting that additional mechanisms besides vinculin activation and F-actin binding determine FA stability. Together, these data show that vinculin activation is critical for FA stabilization and that F-actin binding is dispensable for FA stabilization when vinculin is activated. This suggests that a key role of the vinculin--F-actin interaction in stabilizing FA may be to facilitate vinculin activation or to keep it in an activated state. Together with our previous finding that F-actin binding of PA-vinculin was required to fully restore the growth rate of maturing FA in *Vcl*-KO MEF ([Fig. 7 D](#fig7){ref-type="fig"}), these results suggest that vinculin modulates FA maturation and stabilization by different mechanisms.

Vinculin regulates FA growth rate through effects on F-actin flow
-----------------------------------------------------------------

Our finding that FA grow fast ([Fig. 5, H and I](#fig5){ref-type="fig"}) and yet exert low ECM traction ([Fig. 1, F and G](#fig1){ref-type="fig"}) in cells lacking vinculin appears at odds with the controversial notion that FA maturation and growth are force dependent ([@bib3]; [@bib28]). However, our observation that rates of FA growth and F-actin flow rates both increase in vinculin-deficient cells ([Fig. 1 C](#fig1){ref-type="fig"} and [Fig. 5, H and I](#fig5){ref-type="fig"}) suggests that growth rate of FA and F-actin flow velocity may be linked. To test this, we plotted FA growth and F-actin flow rates within individual FA measured by kymograph analyses of SDC time-lapse sequences of X-rhodamine actin and EGFP-paxillin in control and *Vcl*-KO MEF ([Fig. 8 A](#fig8){ref-type="fig"}). Control and *Vcl*-KO MEF showed indistinguishable linear correlations between FA growth and F-actin flow rates within FA ([Fig. 8, B and C](#fig8){ref-type="fig"}). Remarkably, analysis of *Vcl*-KO MEF coexpressing mApple-actin and either WT, PA, ΔAB, or PA-ΔAB vinculin or EGFP-paxillin ([Fig. 8 D](#fig8){ref-type="fig"}, *Vcl*-KO nontransfected) showed that FA growth rate was linearly related to local F-actin flow velocity, with FA growing at about half the speed of F-actin flow regardless of the presence or absence of vinculin or of the vinculin mutant expressed ([Fig. 8, E and F](#fig8){ref-type="fig"}). Thus, FA growth correlates with F-actin flow rate, independent of vinculin, suggesting that vinculin may attenuate FA growth indirectly by effects on F-actin flow.

![**FA growth rate linearly correlates with local F-actin flow velocity in FA, independently of vinculin.** (A) Kymographs through the long axis of control and *Vcl*-KO MEF showing FA growth rate (EGFP-paxillin, green) and local F-actin flow velocity (X-rhodamine actin, purple) of individual FA. Distal end of FA at top and proximal end at bottom. SDC time-lapses, 10-s frame rate; D, distance; T, time. (B) Plot of FA growth rate versus local F-actin flow velocity for individual FA in control and *Vcl*-KO MEF; *n* = 85 (control) and *n* = 102 (*Vcl*-KO) FA. (C) Box and whisker plot of the ratio of FA growth rate and local F-actin flow velocity for individual FA in control and Vcl-KO MEF; *n* = 85 (control) and *n* = 102 (*Vcl*-KO) FA; means indicated; Student's *t* test. (D) Kymographs through the long axis of FA in *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA showing FA growth (EGFP-paxillin, nontransfected/EGFP-vinculin variants, green) and local F-actin flow velocity (mApple-actin, purple) of individual FA. SDC time-lapses; 5-s frame rate; D, distance; T, time. (E) Plot of FA growth rate versus local F-actin flow velocity for individual FA in *Vcl*-KO MEF expressing the indicated EGFP-vinculin cDNA; *n* = 41 (nontransfected, EGFP-paxillin), *n* = 32 (WT), *n* = 22 (PA), *n* = 30 (ΔAB), and *n* = 22 (PA-ΔAB) FA of 9--16 cells/condition. (F) Box and whisker plot of the ratio of FA growth rate and local F-actin flow velocity for individual FA in Vcl-KO MEF expressing the indicated EGFP-vinculin cDNA; *n* = 41 (nontransfected, EGFP-paxillin), *n* = 32 (WT), *n* = 22 (PA), *n* = 30 (ΔAB), and *n* = 22 (PA-ΔAB) FA of 9--16 cells/condition; means indicated; Student's *t* test. (G) Model for the role of vinculin in FA maturation. Reduced traction stress at FA lacking vinculin is associated with an increased local F-actin flow velocity and a corresponding increase in FA growth rate. We propose that vinculin regulates FA maturation by an indirect mechanism and by engaging retrograde F-actin flow to FA, thus limiting F-actin flow velocity and hence reducing the F-actin flow velocity--dependent growth of FA.](JCB_201303129R_Fig8){#fig8}

Discussion
==========

Our results show for the first time that the FA protein vinculin regulates leading edge F-actin organization and dynamics. Our characterization of a single amino acid substitution in vinculin that specifically disrupts F-actin binding allows the first test of the role of F-actin binding in vinculin functions. We show that the vinculin--F-actin interaction is required to attenuate F-actin retrograde flow in the lamellipodium and for functionally delineating the protrusive lamellipodium from the contractile lamellum ([@bib29]; [@bib19]; [@bib1]; [@bib34]). We demonstrate that through F-actin binding vinculin slows leading edge F-actin retrograde flow at the onset of FA maturation. Together with our demonstration that vinculin promotes traction force at FA, this suggests that vinculin mediates conversion of forces generated in the cytoskeleton that drive retrograde flow into traction force on the ECM during FA maturation. These findings support previous studies showing that vinculin bears force between its head and tail domain ([@bib17]) and that the vinculin tail domain associates with F-actin in cells ([@bib20]). Collectively, these studies implicate vinculin as a component of the molecular clutch, and suggest that vinculin exerts its role in determining the architecture of leading edge F-actin by engaging F-actin flow to the ECM at maturing FA.

Although our findings support the notion that vinculin participates in linking F-actin flow to FA, we observed a partial rescue (50--70%) of F-actin and FA dynamics in *Vcl*-KO MEF by F-actin binding-deficient vinculin. Thus, vinculin may also regulate F-actin dynamics by mechanisms independent of direct F-actin binding. Other vinculin binding partners that could mediate effects on F-actin dynamics include F-actin regulatory proteins such as Arp2/3 ([@bib13]) or VASP ([@bib5]) or partners such as paxillin that regulate signaling to Rho-GTPases ([@bib37]; [@bib12]; [@bib7]). Residual F-actin binding of ΔAB or PA-ΔAB vinculin could also be responsible for the partial rescue, despite the strong reduction in vinculin--F-actin binding observed in vitro. Alternatively, changes in F-actin dynamics produced by vinculin loss could be a result of secondary effects of the highly curved leading edge and lobular lamellipodial morphology observed in the absence of vinculin. However, we found that leading edge lamellipodial curvature and F-actin flow velocity were not correlated, independent of the presence of vinculin or its interaction with F-actin (unpublished data).

Our characterization of an F-actin binding point mutant also allowed us to tease out distinct roles for F-actin binding and vinculin activation in regulating FA dynamics. We found that both vinculin activation and F-actin binding are required for promoting the formation of a high density of nascent FA during lamellipodial protrusion, for inhibiting the transition of nascent to mature FA by stimulating nascent FA disassembly, and for slowing FA growth rate during maturation. However, we uncovered distinct roles for vinculin activation and F-actin binding in FA stabilization. Previous findings showed that loss of vinculin resulted in small FA ([@bib32]), whereas constitutively activated vinculin (T12) or vinculin head induced enlarged, stable FA throughout the ventral cell surface ([@bib20]; [@bib7]), demonstrating vinculin's role in FA stabilization. We found that although F-actin binding was required for FA stabilization in the absence of vinculin preactivation, preactivation of vinculin relieved the requirement of F-actin binding in promoting FA stabilization ([Fig. 7 E](#fig7){ref-type="fig"}). This suggests that vinculin binding to F-actin stabilizes FA by facilitating vinculin activation, rather than through the transmission of cytoskeletal forces to integrins, in agreement with the model of [@bib7]. Furthermore, our demonstration that vinculin inhibits FA maturation but promotes FA stabilization reveals that FA maturation and stabilization are mechanistically distinct processes.

By examining the rate of F-actin retrograde flow within growing FA, we surprisingly found that FA growth rate during maturation correlates with local F-actin flow speed, independent of vinculin or its activation or F-actin binding activities. Furthermore, our data reveal that vinculin promotes strong force transmission but slows growth of FA. This contradicts the notion that FA grow and mature in response to force ([@bib3]). However, this notion has been challenged by recent findings that suggest FA growth is force independent but F-actin dependent ([@bib28]). This agrees with our current finding that FA growth does not correlate with force but depends on the speed of F-actin flow. Together with our previous demonstration that F-actin flow rate dictates ECM traction stress at FA ([@bib16]), our findings strengthen the notion that the velocity of retrograde F-actin flow is a major regulator of FA function. We propose that in addition to direct regulation by interaction with FA proteins, vinculin also regulates FA dynamics by an indirect mechanism, i.e., by engaging retrograde F-actin flow to FA. Slowing F-actin flow rate by vinculin engagement of F-actin to FA could in turn reduce tension on ECM-bound integrins in nascent FA to promote their disassembly and turnover and could also reduce the F-actin flow-dependent growth rate of FA ([Fig. 8 G](#fig8){ref-type="fig"}). Together, our results show that in addition to vinculin's well-established role in FAs vinculin also contributes to cell migration through regulation of leading edge F-actin organization and dynamics and highlight the importance of interdependent feedback between F-actin and FA in leading edge processes.

Materials and methods
=====================

Isolation of primary MEF and *Vcl* disruption
---------------------------------------------

Animals were maintained according to guidelines approved by the National Heart, Lung and Blood Institute Animal Care and Use Committee. Mice were kept on a C57J/BL6 background and PCR genotyped for loxP-modified *Vinculin* (*Vcl*^fl^; [@bib42]). E13.5 embryos from *Vcl*^fl/fl^x*Vcl*^fl/fl^ timed matings were dissected and decapitated, and internal organs were removed. Tissue was cut into pieces and incubated 3× for 10 min in 0.25 mg/ml Trypsin/EDTA (Life Technologies). Single cells were transferred into DMEM/20% FBS after each incubation. Pooled suspensions were passed through 100-µm nylon mesh, and cells were pelleted (5 min at 1,200 rpm) and plated (DMEM/20% FBS) on cell culture dishes. Non-adherent cells were removed after 2 h. 50% of each culture was infected with GFP/cre-expressing adenovirus and 50% with GFP-expressing adenovirus (S. Gutkind, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD). 15--20 h after infection GFP-expressing cells were FACS isolated and cultured for an additional 4 d to obtain vinculin-deficient cells (i.e., *Vcl*-KO) without GFP-cre and control cells without GFP. Cells were maintained in DMEM/20% FBS and passaged up to three times.

Cloning and construction of fluorescent protein conjugates
----------------------------------------------------------

PCR products and restriction digests were purified using the QIAquick gel extraction kit (QIAGEN). Plasmid DNA was purified using the QIAprep Spin Miniprep kit (QIAGEN). Restriction endonucleases were purchased from Life Technologies or New England Biolabs, Inc. The complete sequences for all fluorescent protein constructs were confirmed by sequencing (Florida State University Bioanalytical and Molecular Cloning DNA Sequencing Laboratory). All mApple mammalian expression vectors were constructed using C1 and N1 cloning vectors. Fluorescent protein cDNA was PCR amplified (Phusion Flash; Finnzymes) with a 5′ primer encoding an AgeI site and a 3′ primer encoding a BspEI (C1) or NotI (N1) site for C- or N-terminal fusions, respectively. Purified and digested PCR products were ligated into similarly digested EGFP-C1 and EGFP-N1 vector backbones (Takara Bio Inc.). Fusion target cDNA was PCR amplified with primers containing restriction enzyme sites and ligated into C1 or N1 cloning vectors. To generate fusion vectors, the appropriate cDNA target cloning vector and a mApple C1 or N1 cloning vector were digested with appropriate enzymes and ligated together after gel purification. mApple--paxillin fusion was generated with chicken-paxillin and EcoRI and NotI (A. Horwitz, University of Virginia, Charlottesville, VA; NCBI Nucleotide accession no. [NM_204984.1](NM_204984.1)). mApple fused to β-actin was prepared with human β-actin and NheI and BglII (Takara Bio Inc.; NCBI Nucleotide accession no. [NM_001101.3](NM_001101.3)). EGFP-tagged mutants (N773A/E775A and I997A) of avian vinculin (K. Yamada, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD) were generated using QuikChange site-directed mutagenesis (Agilent Technologies), with sequences verified by DNA sequencing. DNA for mammalian cell transfection was prepared using the Plasmid Maxi kit (QIAGEN). EGFP-tagged Vh 1--821 was obtained from G. Diez (Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany).

Western blot
------------

Cells were scraped for 1 min in ice-cold Laemmli buffer containing protease inhibitors (Roche) and phosphatase inhibitors (Sigma-Aldrich), triturated 8--10× (25-gauge needle), and frozen in aliquots. 10 µg of protein/lane were SDS-PAGE separated and electro-blotted to PVDF membrane (EMD Millipore). Membranes were blocked (5% nonfat dry milk or 3% BSA in TBS/0.1% Tween 20), immunoprobed with primary and HRP-conjugated secondary antibodies, and developed using ECL substrate (GE Healthcare). Antibodies used were as follows: monoclonal anti-vinculin (1:1,000), anti-talin (1:1,000) and anti-cre (1:1,000; Sigma-Aldrich); monoclonal anti-paxillin (1:1,000; BD); monoclonal anti-GAPDH (1:1,000; Cell Signaling Technology); and anti--mouse and --rabbit HRP conjugates (1:10,000; Jackson ImmunoResearch Laboratories, Inc.).

Microinjection and transfection
-------------------------------

Cytoplasmic microinjection of X-rhodamine--labeled actin (0.6 mg/ml; [@bib18]) and EGFP-paxillin cDNA (0.18 µg/µl) was performed on an inverted microscope (TE-200; Nikon) using a microinjector (FemtoJet; Eppendorf) under constant flow (0.3--0.4 psi). MEF were plated onto 10 µg/ml fibronectin (FN)-coated coverslips 15--18 h before microinjection and imaged 3--5 h after injection to ensure EGFP-paxillin expression. MEF for TIRF, SDC, and TFM were nucleofected (solution MEF2, program T20; Lonza) and plated on FN-coated coverslips (10 µg/ml) or FN-coupled polyacrylamide substrates ([@bib31]) 15--18 h before imaging or fixation.

Microscopy
----------

SDC-FSM of X-rhodamine actin or mApple-actin and EGFP-paxillin was performed on an inverted microscope system (TE2000E2; Nikon; [@bib36]) using a 100×/1.49 NA Apo TIRF objective lens. Pairs of X-rhodamine or mApple-actin and EGFP images were captured every 10 s. The same system was used with a 60×/1.2 NA Plan Apo violet-corrected water immersion objective and 1.5× beam expansion for TFM of EGFP-paxillin expressing MEF on FN-coupled polyacrylamide substrates embedded with 0.15% red (580/605 nm) and far-red (660/680 nm) fluorescent beads (40 nm; Invitrogen). Image triplets of EGFP and the two bead colors were acquired before and after cell detachment via trypsin perfusion. The system was also used for TIRF microscopy of EGFP-paxillin and mApple-actin in control and Vcl-KO MEF on FN-coated coverslips. Pairs of EGFP and mApple images were taken every 2 s using a 100×/1.49 NA Apo TIRF objective and an evanescent field depth of ∼150 nm. TIRF microscopy of EGFP-paxillin, EGFP-vinculin mutants, and mApple-actin in Vcl-KO MEF on FN coated coverslips was performed on an inverted microscope system (Eclipse Ti; Nikon). Pairs of EGFP and mApple images were taken every 3 s using a 100×/1.49 NA Apo TIRF objective and an evanescent field depth of ∼150 nm. Long-term time-lapse phase-contrast imaging of single MEF migrating on FN-coated coverslips was performed on an inverted microscope (TE300; Nikon) using a 10×/0.25 NA Plan objective and 0.52 NA condenser. Images were taken every 10 min for 12 h. Differential interference contrast imaging of MEF migrating on FN-coated coverslips was performed on the same system using a 60×/1.49 NA Apo TIRF objective and 0.85 NA condenser. Paxillin immunofluorescence micrographs for FA size quantifications were acquired on the TIRF/SDC system described above ([@bib36]) using 100× or 60×/1.49 NA Apo TIRF objective lenses or an SP5 laser scanning microscope system using a 100×/1.46 NA Plan Apo objective lens (LAS AF acquisition software; Leica). Epifluorescence images of cells stained for paxillin, cortactin, pS19MLC-2 or MLC-2, and/or Alexa Fluor 488--phalloidin staining were acquired on either the TIRF/SDC or the TE300-based Epifluorescence system described above using a 100×/1.49 NA Apo TIRF objective. All functions on the TIRF, SDC, and epifluorescence microscope systems were controlled using MetaMorph software (Molecular Devices); temperature was maintained at 37°C (airstream incubator; Nevtek); and images were acquired using a cooled charge-coupled device (CoolSNAP-HQ2; Photometrics) operated in 14-bit read-out mode. Laser scanning confocal microscopy of EGFP-tagged vinculins for FA persistence quantification was performed on an SP5 microscope system (LAS AF acquisition software) at 37°C (whole stage incubation chamber; Leica) using a 63×/1.4 NA Plan Apo objective lens at a frame rate of 2 min. All live cell experiments were performed using Phenol red--free DMEM containing 5% FCS, 20 mM Hepes, and 10 U/ml oxyrase as imaging medium.

Immunofluorescence
------------------

Cells were fixed in 4% paraformaldehyde/PBS, permeabilized 5 min in 0.5% Triton X-100/PBS, and blocked (2% BSA and 0.02% Triton X-100/PBS) for 1 h at RT, followed by overnight incubation (4°C) with primary antibodies, 3× washing (PBS), and secondary antibody incubation (1 h at RT), before mounting in fluorescent mounting medium (Dako) or PBS (TIRF microscopy). Alexa Fluor 488--phalloidin (1:400; Invitrogen) was included in the secondary antibody solution where indicated. Antibodies used were as follows: monoclonal anti-vinculin (1:250), anti-talin (1:200) and polyclonal rabbit anti-vinculin (1:100; Sigma-Aldrich); monoclonal anti-paxillin (1:100; BD); monoclonal anti-FAK (1:250; Invitrogen); rat monoclonal anti-β1integrin (9EG7; 1:100; BD); rabbit polyclonal anti-cortactin (1:100), anti-Vasp (1:100), anti-pS19 myosin light chain-2 (1:50), and monoclonal anti-myosin light chain-2 (1:50; Cell Signaling Technology). Rabbit polyclonal anti-zyxin (1:1,000) was provided by M. Beckerle (Huntsman Cancer Institute, Salt Lake City, UT). Anti--rabbit, --mouse, and --rat fluorophore conjugates (1:500) were obtained from Jackson ImmunoResearch Laboratories, Inc.

Image analysis
--------------

### Cell area.

Cells in phase-contrast images were manually outlined (MetaMorph) and the segmented area was determined.

### Cell migration velocity.

Nuclei were manually tracked (MetaMorph) and instantaneous velocities (displacement per time between consecutive frames) were determined and averaged for each cell.

### Spatial distribution of FA, F-actin, and pS19MLC2.

Fluorescence intensity distributions of paxillin, Alexa Fluor 488--phalloidin, and pS19MLC2 were recorded along line scans (4--8-µm wide, orthogonal to leading edge); leading edge position was defined by increase of Alexa Fluor 488--phalloidin intensity above extracellular background and extracellular background was subtracted. Paxillin images were additionally background flattened (7-pixel kernel) to compensate for cytoplasmic background.

### FA size distribution.

TIRF or SDC or laser scanning confocal images of paxillin immunofluorescence stainings were manually thresholded, binarized, and morphologically filtered ("open-close," 2-pixel kernel) to include small FA. Segmented area of thresholded regions was then determined (MetaMorph).

### Nascent FA formation density.

TIRF image sequences of MEF expressing EGFP-paxillin and mApple-actin during leading edge protrusion were analyzed for the number of newly assembling nascent FA within the boundaries of the protruding lamellipodium. Diffraction-limited (∼0.1 µm^2^) EGFP-paxillin fluorescence intensity maxima that were stable for \>6--8 s were counted as nascent FA, whereas short-lived (2--4 s) diffraction-limited intensity maxima were excluded. The leading edge in the region of interest was outlined on each frame in the mApple-actin image to normalize adhesion counts per lamellipodial area gained.

### Nascent FA assembly time and lifetime.

EGFP-paxillin fluorescence intensity within nascent FA was recorded and local background was subtracted over time. Time elapsed between the onset of intensity increase and intensity maximum was defined as assembly time.

### FA growth.

SDC time-lapses of EGFP-paxillin expressing MEF were analyzed via kymographs aligned along the axis of adhesion elongation, and growth rate was calculated as elongation at the proximal FA tip over time.

### Local F-actin flow velocity within maturing FA.

The same kymograph used to determine the growth of individual FA was applied to the X-rhodamine/mApple channel to determine F-actin flow within the FA at the given time.

### Lamellipodium width.

Cortactin immunofluorescence intensity distributions along line scans (perpendicular to leading edge through the lamellipodium; 1.2-µm wide), placed at 15--20-µm intervals along the leading cell edge, were recorded in epifluorescence images. Extracellular background was subtracted, and the width of the intensity distribution at I~max/2~ was defined as lamellipodium width.

### SDC-FSM of X-rhodamine actin/mApple-actin and EGFP-paxillin/EGFP-vinculin mutants.

F-actin flow analysis was performed using fsmCenter software (MatLab; Mathworks) as described previously ([@bib11]). Mean F-actin flow rates in lamellipodia and lamellae were quantified from F-actin speed maps of leading edge protrusion phases. Lamellipodia and lamelllae areas were manually outlined for each frame based on FSM F-actin images. Lamellipodia were defined as the region of fast F-actin flow abutting the cell edge and lamelllae were defined as the region just proximal to the lamellipodia. Automated FA tracking and grouping of F-actin flow velocities based on their proximity to FA was based on a custom-written FA detection and tracking algorithm (see the computational source code in the online supplemental material). In brief, EGFP-paxillin images of control and Vcl-KO MEF were filtered using a fourth order steerable filter ([@bib21]) and local maxima were extracted. An anisotropic Gaussian model was then fitted to each local maximum. A goodness-of-fit test on the residual of each fit and a Student's *t* test on each estimated model parameter were performed to remove outliers (significance level P = 0.05). Detected features were then tracked using uTrack ([@bib22]), with gap closing and linear motion estimation modes enabled. Individual tracks were then grouped together to reconstruct FA over time. Grouping was achieved in a graph-matching procedure that globally maximized a pairwise score function computed between tracks. The score function evaluated the relative proximity of the two tracks and their alignment. Alignment was measured according to the orientation of the features provided by the fitting step and the main direction of the tracks. Pairs of tracks were discarded if their mean pairwise distance was \>400 nm within the first 2 µm away from the cell edge or \>1.5 µm elsewhere. F-actin speed was then assigned to each detected FA by gathering all speckles lying within the vicinity of each adhesion. FA vicinity at each frame was defined as the set of pixels falling into a 5-pixel (335 nm) radius around the detected adhesion. Lamellipodium--lamellum border for automated, region-specific F-actin speed measurements outside of segmented adhesions was defined based on lamellipodium width measurements shown in [Fig. 2 E](#fig2){ref-type="fig"} and was set at a distance of 1.7 µm from the leading edge as a common cutoff for both control and *Vcl*-KO MEF.

### TFM.

Fourier-transformed traction cytometry was used to reconstruct traction stresses from the displacement field ([@bib31]). Images of deformed and relaxed substrates were aligned to compensate for stage drift and movement of microspheres was quantified with sub-pixel accuracy using custom-written MatLab software ([@bib16]; [@bib31]). To measure traction exerted by individual FA, the traction vectors in the vicinity of large, spatially separated FA were summed and normalized to FA area.

### FA persistence.

All FA present at the beginning of 1-h laser scanning confocal time-lapse series of EGFP-vinculin (variants) expressing cells were manually tracked over time to record the fraction of FA that did not disassemble within 1 h. FA persistence was calculated as the ratio of persistent to total initial FA.

Vinculin protein expression and purification
--------------------------------------------

Full-length chicken vinculin was cloned into a pET15b vector, and the I997A point mutation was generated using QuikChange site-directed mutagenesis, with sequences verified by DNA sequencing. Vinculin protein expression and purification have been reported previously ([@bib2]). In brief, *Escherichia coli* BL21(DE3)RIPL (Agilent Technologies) cells transformed with vinculin plasmids were grown in Lysogeny broth-rich media at 37°C to an *A*~600~ of 0.6. The cultures were cooled to 18°C before adding isopropyl β-d-1-thiogalactopyranoside to a final concentration of 0.5 mM to induce vinculin expression overnight. Cells were pelleted (5,800 *g*, 30 min), resuspended in lysis buffer (50 mM Tris, 500 mM NaCl, 5 mM imidazole, and 5 mM β-mercaptoethanol, pH 8.0), and sonicated. The lysates were clarified (25,000 *g*, 40 min) and the supernatant was loaded onto a nickel affinity column (QIAGEN) and washed twice with a nickel wash buffer (50 mM Tris, 500 mM NaCl, 10 mM imidazole, and 5 mM β-mercaptoethanol, pH 8.0). Histidine-tagged vinculin protein was then eluted with a nickel elution buffer (50 mM Tris, 500 mM NaCl, 500 mM imidazole, and 5 mM β-mercaptoethanol, pH 8.0). The His tag was removed by thrombin (Sigma-Aldrich) addition before further purification by anion exchange (Hiprep Q XL 16/10) fast protein liquid chromatography (GE Healthcare) and size exclusion using Sephacryl S-200 media (GE Healthcare). All vinculin variants were examined by SDS-PAGE to assess purity and protein integrity before being used for biochemical assays. Protein concentrations were determined before each experiment using the following methods. For actin, protein concentration was determined using the Bio-Rad Laboratories protein assay. For vinculin, concentration was determined by measuring absorbance at 280 nm and calculated using the extinction coefficient 17,990. IPA peptide was synthesized and a 1-M stock solution was made based on the molecular mass of the peptide.

F-actin cosedimentation assay
-----------------------------

F-actin binding/bundling properties of vinculin variants were assessed using an adapted F-actin cosedimentation assay ([@bib35]). In brief, G-actin purified from rabbit muscle acetone powder (Pel-Freez Biologicals) was polymerized with an equal volume of 2× actin polymerization buffer (20 mM Tris, 200 mM KCl, 5 mM MgCl~2~, and 4 mM dithiothreitol, pH 7.5) at RT for 30 min. To assess F-actin binding of the vinculin variants, 100-µl samples in actin polymerization buffer containing actin at concentrations ranging from 0 to 30 µM,10 µM of vinculin protein, and 100 µM of IpaA peptide (Ac-NNIYKAAKDVTTSLSKVLKNIN-NH2) were incubated at RT for 1 h. The reported F-actin concentration was calculated using the concentration of G-actin before polymerization. The samples were centrifuged at high speed (184,200 *g*) on a TLA 100 rotor (Beckman Coulter) for 30 min at 25°C. For bundling assays, 200-µl samples in actin polymerization buffer containing 20 µM of actin, 10 µM of vinculin protein, and 100 µM of IpaA peptide were incubated at RT for 1 h. Samples containing F-actin bundles were obtained by careful extraction of the supernatant after low speed centrifugation (5,000 *g*). The pellet was resuspended in 200 µl of 0.1% SDS buffer (0.1% SDS, 25 mM glycine, and 25 mM Tris, pH 8.3). Actin and vinculin protein in supernatant and solubilized pellet were SDS-PAGE separated (15%) and densitometrically quantified using ImageJ software. Vinculin binding percentages were calculated using the following formula:$$\%\,\text{vinculin}\,\text{bound} = \frac{\text{vinculin}_{\text{pellet}}}{\text{vinculin}_{\text{pellet}}{+ \text{vinculin}}_{\text{supernatant}}}.$$

Fluorescence microscopy of F-actin bundles
------------------------------------------

F-actin bundles induced by addition of WT or I997A vinculin were visualized using fluorescence microscopy as previously described ([@bib35]). Samples were prepared following conditions described for the F-actin bundling assay. In brief, 20 µM of prepolymerized F-actin and IpaA petide were incubated with 0 or 10 µM WT or I997A vinculin at RT for 1 h. The mixture was diluted 20× with actin polymerization buffer (10 mM Tris, 100 mM KCl, 2.5 mM MgCl~2~, and 2 mM dithiothreitol, pH 7.5). Alexa Fluor 488--phalloidin (Invitrogen) was added to the mixture to a final concentration of 1.5 µM and then incubated at RT for 5 min. The sample was diluted to an actin concentration of 50 nM. 5-µl aliquots were placed on a glass slide and covered with a coverslip. Fluorescence images were acquired on an Axiovert 200M microscope (Carl Zeiss) using a 60× objective and an ORCA-ERAG digital camera (Hamamatsu Photonics).

Statistical analysis
--------------------

Normally distributed data were analyzed using a two-tailed Student's *t* test, unequal variance, and significance value specific for each analysis (0.05 if not mentioned). Non-normally distributed data were analyzed using a Mann-Whitney *U* test with significance value specific for each analysis (0.05 if not mentioned). Large samples gathered from automated measurements ([Fig. 1 E](#fig1){ref-type="fig"}) were subsampled by selecting 1,000 data points.

Online supplemental material
----------------------------

Video 1 shows the morphology of live control and *Vcl*-KO MEF. Video 2 shows the random migration of control and *Vcl*-KO MEF. Video 3 shows F-actin dynamics in control and *Vcl*-KO MEF. Video 4 is an overlay of F-actin flow and FA in control and *Vcl*-KO MEF. Video 5 shows F-actin dynamics in *Vcl*-KO MEF expressing EGFP-WT or -PA vinculin. Video 6 shows F-actin dynamics in *Vcl*-KO MEF expressing EGFP-ΔAB or EGFP-PA-ΔAB vinculin. Video 7 shows nascent FA dynamics in control and *Vcl*-KO MEF. Video 8 shows FA maturation in control and *Vcl*-KO MEF. Video 9 shows nascent FA dynamics in *Vcl*-KO MEF expressing EGFP-WT or -PA vinculin. Video 10 shows nascent FA dynamics in *Vcl*-KO MEF expressing EGFP-ΔAB or EGFP-PA-ΔAB vinculin. Fig. S1 shows the generation and basic characterization of primary vinculin-deficient MEF from *Vcl^fl/fl^* mice. Fig. S2 shows detection and tracking of local intensity maxima of nascent and maturing FA on SDC time-lapse sequences of EGFP-paxillin expressing MEF. Fig. S3 shows that loss of vinculin differently affects small peripheral FA and mature FA. Fig. S4 shows that reexpression of full-length vinculin restores nascent FA and normal FA organization in *Vcl*-KO MEF. Fig. S5 shows colocalization of EGFP-vinculin mutants with mApple-paxillin in nascent FA and comparable FA growth rates measured by FA labeling with mApple-paxillin and EGFP-vinculin mutants. The computational source code for FA detection and tracking algorithm with instructions is also included. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201303129/DC1>.
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